231 related articles for article (PubMed ID: 32227190)
1. Heritable arrhythmias associated with abnormal function of cardiac potassium channels.
Crotti L; Odening KE; Sanguinetti MC
Cardiovasc Res; 2020 Jul; 116(9):1542-1556. PubMed ID: 32227190
[TBL] [Abstract][Full Text] [Related]
2. Short QT syndrome. Update on a recent entity.
Maury P; Extramiana F; Sbragia P; Giustetto C; Schimpf R; Duparc A; Wolpert C; Denjoy I; Delay M; Borggrefe M; Gaita F
Arch Cardiovasc Dis; 2008; 101(11-12):779-86. PubMed ID: 19059573
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics and cardiac ion channels.
Roepke TK; Abbott GW
Vascul Pharmacol; 2006 Feb; 44(2):90-106. PubMed ID: 16344000
[TBL] [Abstract][Full Text] [Related]
4. Disorders of cardiac repolarization: long QT and short QT syndromes.
Horie M; Itoh H
Circ J; 2007; 71 Suppl A():A50-3. PubMed ID: 17587740
[TBL] [Abstract][Full Text] [Related]
5. The Kir2.1E299V mutation increases atrial fibrillation vulnerability while protecting the ventricles against arrhythmias in a mouse model of short QT syndrome type 3.
Moreno-Manuel AI; Macías Á; Cruz FM; Gutiérrez LK; Martínez F; González-Guerra A; Martínez Carrascoso I; Bermúdez-Jimenez FJ; Sánchez-Pérez P; Vera-Pedrosa ML; Ruiz-Robles JM; Bernal JA; Jalife J
Cardiovasc Res; 2024 Apr; 120(5):490-505. PubMed ID: 38261726
[TBL] [Abstract][Full Text] [Related]
6. Repolarization gradients and arrhythmogenicity in the murine heart.
Killeen MJ; Sabir IN
J Physiol; 2007 Sep; 583(Pt 2):419-20. PubMed ID: 17627980
[No Abstract] [Full Text] [Related]
7. Potassium-channel mutations and cardiac arrhythmias--diagnosis and therapy.
Giudicessi JR; Ackerman MJ
Nat Rev Cardiol; 2012 Jan; 9(6):319-32. PubMed ID: 22290238
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities in sodium current and calcium homoeostasis as drivers of arrhythmogenesis in hypertrophic cardiomyopathy.
Coppini R; Santini L; Olivotto I; Ackerman MJ; Cerbai E
Cardiovasc Res; 2020 Jul; 116(9):1585-1599. PubMed ID: 32365196
[TBL] [Abstract][Full Text] [Related]
9. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.
Thomas D; Karle CA; Kiehn J
Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic manifestations of mutations in genes encoding subunits of cardiac potassium channels.
Shimizu W; Horie M
Circ Res; 2011 Jun; 109(1):97-109. PubMed ID: 21700951
[TBL] [Abstract][Full Text] [Related]
11. Familial and acquired long qt syndrome and the cardiac rapid delayed rectifier potassium current.
Witchel HJ; Hancox JC
Clin Exp Pharmacol Physiol; 2000 Oct; 27(10):753-66. PubMed ID: 11022966
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological activation of IKr in models of long QT Type 2 risks overcorrection of repolarization.
Perry MD; Ng CA; Mangala MM; Ng TYM; Hines AD; Liang W; Xu MJO; Hill AP; Vandenberg JI
Cardiovasc Res; 2020 Jul; 116(8):1434-1445. PubMed ID: 31628797
[TBL] [Abstract][Full Text] [Related]
13. Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children.
Antzelevitch C
J Electrocardiol; 2001; 34 Suppl():177-81. PubMed ID: 11781953
[TBL] [Abstract][Full Text] [Related]
14. Heritable arrhythmia syndromes associated with abnormal cardiac sodium channel function: ionic and non-ionic mechanisms.
Rivaud MR; Delmar M; Remme CA
Cardiovasc Res; 2020 Jul; 116(9):1557-1570. PubMed ID: 32251506
[TBL] [Abstract][Full Text] [Related]
15. Distinct gene-specific mechanisms of arrhythmia revealed by cardiac gene transfer of two long QT disease genes, HERG and KCNE1.
Hoppe UC; Marbán E; Johns DC
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5335-40. PubMed ID: 11320260
[TBL] [Abstract][Full Text] [Related]
16. Fast and furious: new ways to think about, study and treat cardiac arrhythmias.
Joyner MJ; Nattel S
J Physiol; 2009 Apr; 587(Pt 7):1383-4. PubMed ID: 19336610
[No Abstract] [Full Text] [Related]
17. Pharmacology of cardiac potassium channels.
Tamargo J; Caballero R; Gómez R; Valenzuela C; Delpón E
Cardiovasc Res; 2004 Apr; 62(1):9-33. PubMed ID: 15023549
[TBL] [Abstract][Full Text] [Related]
18. Human Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue as a Sensitive Test System for QT Prolongation and Arrhythmic Triggers.
Lemoine MD; Krause T; Koivumäki JT; Prondzynski M; Schulze ML; Girdauskas E; Willems S; Hansen A; Eschenhagen T; Christ T
Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006035. PubMed ID: 29925535
[TBL] [Abstract][Full Text] [Related]
19. Cardiac arrhythmia and thyroid dysfunction: a novel genetic link.
Purtell K; Roepke TK; Abbott GW
Int J Biochem Cell Biol; 2010 Nov; 42(11):1767-70. PubMed ID: 20688187
[TBL] [Abstract][Full Text] [Related]
20. Modulation of HERG potassium channel function by drug action.
Thomas D; Karle CA; Kiehn J
Ann Med; 2004; 36 Suppl 1():41-6. PubMed ID: 15176423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
